Celldex

Life Sciences

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate.

  • Sector Life Sciences

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate.

Our pipeline includes antibodies, antibody-drug conjugates and other protein-based therapeutics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases.

Visit website

Contact us

Thank you for your enquiry!
We'll be in touch soon.

We couldn't send your message.
Please review the fields then try again